Literature DB >> 25769329

[Effect and mechanism of fluorofenidone on organ fibrosis].

Hong Ma1, Zhangzhe Peng, Gaoyun Hu, Lijian Tao.   

Abstract

Fibrosis can occur in different organs with high incidence rate and great danger. It still lacks effective drugs for prevention of fibrosis. Fluorofenidone is a newly developed drug with anti-fibrotic activity, which provides a new hope for treating the progressive fibrotic diseases. Recent studies have shown that fluorofenidone is a multifunctional small molecule with anti-inflammatory, antioxidative and anti-apoptotic eff ects. It can inhibit the activation and proliferation of myofibroblasts, promote the degradation of extracellular matrix and regulate the cellular signal transmission. Fluorofenidone can be applied to attenuate the progression of renal, hepatic and pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25769329     DOI: 10.11817/j.issn.1672-7347.2015.02.016

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  3 in total

1.  Fluorofenidone Inhibits the Proliferation of Lung Adenocarcinoma Cells.

Authors:  Zheng-Hao Deng; Jie Meng; Juan Tang; Gao-Yun Hu; Li-Jian Tao
Journal:  J Cancer       Date:  2017-07-04       Impact factor: 4.207

2.  Fluorofenidone attenuates paraquat‑induced pulmonary fibrosis by regulating the PI3K/Akt/mTOR signaling pathway and autophagy.

Authors:  Feiya Jiang; Sha Li; Yu Jiang; Zhuo Chen; Tongtong Wang; Wen Liu
Journal:  Mol Med Rep       Date:  2021-03-31       Impact factor: 2.952

3.  Fluorofenidone inhibits apoptosis of renal tubular epithelial cells in rats with renal interstitial fibrosis.

Authors:  Hui Yang; Weiru Zhang; Tingting Xie; Xuan Wang; Wangbin Ning
Journal:  Braz J Med Biol Res       Date:  2019-10-28       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.